Halil Aşçı
Impact in
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
- Biophysics top 10%
- Electromagnetic Fields and Biological Effects
Papers in
-
- Chemotherapy-induced organ toxicity mitigation 9
- Epidemiology 11
- Preterm Birth and Chorioamnionitis 4
- Liver Disease Diagnosis and Treatment 4
- Co-authors
- Özlem Özmen (37 shared papers)Mehtap Savran (25 shared papers)İlter İlhan (21 shared papers)Hamit Yaşar Elli̇dağ (2 shared papers)Necat Yılmaz (1 shared paper)Yalçın Erzurumlu (15 shared papers)Mehmet Kaya Özer (5 shared papers)Mustafa Saygın (6 shared papers)
- Journals
- Molecular Biology Reports (7 papers)Immunopharmacology and Immunotoxicology (4 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (3 papers)Renal Failure (2 papers)Journal of Molecular Histology (2 papers)
- Partner nations
- TürkiyeKazakhstanCzechia
In The Last Decade
Halil Aşçı
63 papers receiving 522 citations
Peers
Comparison fields: 5 of 98
- Pharmacology 47
- Biophysics 32
- Pathology and Forensic Medicine 83
- Complementary and alternative medicine 36
- Nephrology 27
Countries citing papers authored by Halil Aşçı
This map shows the geographic impact of Halil Aşçı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halil Aşçı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halil Aşçı more than expected).
Fields of papers citing papers by Halil Aşçı
This network shows the impact of papers produced by Halil Aşçı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halil Aşçı. The network helps show where Halil Aşçı may publish in the future.
Co-authors
The 25 scholars most cited alongside Halil Aşçı, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 89 | |
| 2 | 2015 | 39 | |
| 3 | 2009 | 31 | |
| 4 | 2019 | 29 | |
| 5 | 2015 | 27 | |
| 6 | 2020 | 22 | |
| 7 | 2011 | 18 | |
| 8 | 2013 | 16 | |
| 9 | 2022 | 15 | |
| 10 | 2014 | 15 | |
| 11 | 2015 | 14 | |
| 12 | 2023 | 12 | |
| 13 | 2023 | 11 | |
| 14 | 2021 | 11 | |
| 15 | 2022 | 10 | |
| 16 | 2023 | 10 | |
| 17 | 2022 | 9 | |
| 18 | 2018 | 9 | |
| 19 | 2017 | 8 | |
| 20 | 2023 | 8 |
About Halil Aşçı
Halil Aşçı is a scholar working on Pathology and Forensic Medicine, Epidemiology, Public Health, Environmental and Occupational Health, Molecular Biology and Surgery, having authored 77 papers that have together received 536 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (9 papers), Acute Lymphoblastic Leukemia research (6 papers), Preterm Birth and Chorioamnionitis (4 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Electromagnetic Fields and Biological Effects (4 papers), Reproductive System and Pregnancy (3 papers) and Acute Kidney Injury Research (3 papers). The work is most often cited by research in Pharmacology (47 citations), Biophysics (32 citations), Pathology and Forensic Medicine (83 citations), Complementary and alternative medicine (36 citations) and Nephrology (27 citations). Halil Aşçı has collaborated with scholars based in Türkiye, Kazakhstan and Czechia. Frequent co-authors include Özlem Özmen, Mehtap Savran, İlter İlhan, Hamit Yaşar Elli̇dağ, Necat Yılmaz, Yalçın Erzurumlu, Mehmet Kaya Özer, Mustafa Saygın, Şükriye Yeşilot and Duygu Kumbul Doğuç. Their work appears in journals such as Molecular Biology Reports, Immunopharmacology and Immunotoxicology, Naunyn-Schmiedeberg s Archives of Pharmacology, Renal Failure and Journal of Molecular Histology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.